In addition, ITF2 was found deleted or downregulated in other epithelial tumors, such as esophageal adenocarcinoma (186 patients) or head and neck Squamous cell carcinoma SCC (522 patients), where ITF2 loss also predicted a worse overall survival (Figure S3C,D). This evidence concerns the gene TCF4 and esophageal adenocarcinoma.